Susan Lynn Secore

Title: Susan Lynn Secore: Innovator in Vaccine Development

Introduction

Susan Lynn Secore is a notable inventor based in Telford, PA (US). She has made significant contributions to the field of vaccine development, particularly in relation to clostridium difficile. Her innovative work focuses on creating vaccines that utilize recombinant toxins to combat infections.

Latest Patents

Susan Lynn Secore holds a patent for "Vaccines against clostridium difficile comprising recombinant toxins." This invention relates to recombinant toxin A (TcdA) and toxin B (TcdB), as well as binary toxin A (CDTa) proteins that have been specifically mutated to reduce or eliminate toxicity. The patent also covers vaccines and immunogenic compositions that include these recombinant toxins, which are designed to provide protection against infections. Furthermore, the invention encompasses methods for inducing an immune response through the administration of these vaccines and immunogenic compositions.

Career Highlights

Secore's career is marked by her dedication to advancing medical science through innovative vaccine research. She has successfully developed methods for expressing recombinant toxins in various expression systems, including the baculovirus/insect cell expression system. Her work has the potential to significantly impact public health by providing effective solutions against clostridium difficile infections.

Collaborations

Throughout her career, Susan has collaborated with esteemed colleagues such as Jon Henry Heinrichs and Jean-Luc Bodmer. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Susan Lynn Secore is a pioneering inventor whose work in vaccine development showcases her commitment to improving health outcomes. Her innovative approaches to combating clostridium difficile infections through recombinant toxins highlight the importance of research and collaboration in the field of medicine.